PPIPT02259
Target Protein Information
| Protein_Name | Protein S100-B |
|---|---|
| Protein_Sequence | MSELEKAMVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDNDGDGECDFQEFMAFVAMVTTACHEFFEHE |
| Organism_Source | Homo sapiens |
| Functional_Classification | Calcium-binding regulatory protein (EF-hand family) |
| Cellular_Localization | Cytoplasm |
| Gene_Names | S100B |
| UniProt_ID | P04271 |
| Protein-Protein Interaction Networks | |
Peptide Basic Information
| Peptide_Name | pBBDR-TRTK |
|---|---|
| Peptide_Sequence | RRRRRRRTXTKIDWXKILXKX |
| Peptide_Length | 21 |
| Peptide_SMILES | CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O |
| Chemical_Modification | X8=Aib; X14=Aib; X18=Aib; X20=Ahx |
| Cyclization_Method | none |
| Linear/Cyclic | Linear |
| N-terminal_Modification | hexa-arginine tag |
| C-terminal_Modification | free |
| Amino_Acid_Distribution | |
|
|
|
Peptide Physicochemical
| Molecular_Weight | 2567.05 |
|---|---|
| Aliphatic_Index | 55.71429 |
| Aromaticity | 0.04762 |
| Average_Rotatable_Bonds | 4.42857 |
| Charge_at_pH_7 | 8.99752 |
| Isoelectric_point | 12.90508 |
|---|---|
| Hydrogen_Bond_Acceptors | 35 |
| Hydrogen_Bond_Donors | 50 |
| Topological_Polar_Surface_Area | 1250.23000 |
| X_logP_energy | -14.05161 |
Interaction Information
| Affinity | KD=7.7 nM |
|---|---|
| Affinity_Assay | fluorescence anisotropy |
| PDB_ID | None |
| Type | Inhibitor |
| Structure | |
Reference Information
| Document_Type | Patent |
|---|---|
| Title | NOVEL HIGH AFFINITY BIVALENT HELICALLY CONSTRAINED PEPTIDE AGAINST CANCER (:contentReference[oaicite:4]{index=4}) |
| Release_Year | 2014 |
| Patent_ID | US20140155331A1 |